VA/DoD Diabetes Mellitus Primary Care Practice Guideline
This paper examines the 2017 VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus in Primary Care, a Level I evidence-based framework developed for use across Department of Defense and Veterans Affairs health care systems. The paper provides an overview of the guideline's purpose, diagnostic criteria, and algorithmic decision-making structure, then discusses how multidisciplinary health care professionals are held to its recommendations through shared decision-making and patient-centered care. It also identifies the research evidence base — including systematic reviews and randomized controlled trials following the PICOTS framework — and concludes with an assessment of how consistently professionals have followed and updated the guideline since its original 2003 publication.
- Introduction to the Guideline: Overview of 2017 VA/DoD diabetes management guideline
- Professional Accountability and Shared Decision-Making: How clinicians and staff apply guideline recommendations
- Research and References Supporting the Guideline: Algorithm format and clinical decision-making process
- Diagnostic Evidence and Criteria: Biomarker thresholds for diagnosing diabetes and prediabetes
- Level of Evidence in the Practice Guideline: Level I evidence from RCTs and systematic reviews
- Professional Adherence and Guideline Updates: History of guideline revisions and professional compliance
- Conclusion: Summary of guideline goals and expected patient outcomes
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper grounds each section in the actual text of the 2017 VA/DoD guideline, ensuring claims are traceable to authoritative sources rather than unsupported assertions.
- It covers a logical progression from guideline overview, to professional accountability, to evidence definitions, to adherence opinion — creating a coherent analytical arc.
- Concrete diagnostic criteria presented in a structured table give readers actionable clinical reference points, strengthening the paper's practical value.
Key academic technique demonstrated
The paper demonstrates effective use of evidence hierarchies in health sciences writing. By explicitly identifying the guideline as Level I evidence — based on systematic reviews and meta-analyses of randomized controlled trials following the PICOTS framework — the author shows an understanding of how evidence quality is evaluated and communicated in clinical contexts. This technique, anchored by a citation to Burns et al. (2011), models how students should justify the strength of evidence-based recommendations in health care policy papers.
Structure breakdown
The paper follows a prompted structure common to undergraduate health sciences courses: introduction to the guideline, discussion of professional accountability, identification of supporting research, definition of the evidence base, determination of evidence level, opinion on adherence, and a synthesizing conclusion. Each section directly addresses a specific prompt question, making the organizational logic transparent. The conclusion effectively recaps all major threads — shared decision-making, evidence quality, and expected patient outcomes — in a concise summary.
Introduction to the Guideline
There are numerous areas within health care that demand change in everyday practice. More often than not, irrespective of the healthcare setting, an inventive group is required to conduct research and facilitate change. This is accomplished through the establishment and advancement of clinical practice guidelines. The selected healthcare system practice guideline examined in this paper is the Management of Diabetes Mellitus in Primary Care (2017). This guideline delineates the important decision points in the management of Diabetes Mellitus (DM) and provides well-outlined, wide-ranging, evidence-based recommendations integrating prevailing information and practices for practitioners throughout the Department of Defense (DoD) and Veterans Affairs (VA) Health Care Systems.
Diabetes mellitus is an illness caused either by an absolute or relative deficiency in insulin, giving rise to hyperglycemia. Type 1 DM (T1DM) results from insufficient insulin secretion that does not originate from insulin resistance, whereas Type 2 DM (T2DM) results from insulin resistance that can ultimately also give rise to insulin secretion insufficiency.
The main purpose of this guideline is to enhance patient outcomes and the local management of patients suffering from diabetes mellitus (U.S. Department of Veterans Affairs, 2017). This clinical practice guideline is not intended to act as a standard of care. Standards of care are determined based on all clinical data accessible for an individual patient and are subject to change as scientific knowledge, technology, and practice patterns evolve. This clinical practice guideline is centered on information available at the time of publication and is meant to provide an overall guide to best practices. Furthermore, while this guideline can be beneficial to care providers, its utilization must at all times be treated as a recommendation, within the framework of a provider's clinical judgment and patient values and preferences, for the care of an individual patient (U.S. Department of Veterans Affairs, 2017).
The broad objective of evidence-based guidelines in the healthcare system is to enhance the health and well-being of patients by providing direction to health providers — particularly in primary care — regarding management approaches that are supported by evidence. The anticipated outcome of effective implementation of this guideline is to emphasize shared decision-making in establishing patient objectives, appraising the patient's situation, and determining, in conjunction with the patient, the treatment approaches needed to attain those goals. Most importantly, the guideline aims to reduce the risk of preventable complications while simultaneously improving quality of life.
Professional Accountability and Shared Decision-Making
This clinical practice guideline is centered on a systematic review of both clinical and epidemiological evidence. Having been created and advanced by a panel of multidisciplinary specialists, it offers a clear elucidation of the relationships between different care options while rating both the quality of the evidence and the strength of the recommendations. Variations in practice will appropriately occur when clinicians take into consideration the needs of individual patients, available resources, and constraints specific to an institution or type of practice. Every health care professional utilizing these guidelines is accountable for evaluating the appropriateness of applying them in the context of any particular clinical circumstance (U.S. Department of Veterans Affairs, 2017).
Throughout the guideline, clinicians and health care professionals are encouraged to emphasize shared decision-making (SDM). Patients with Diabetes Mellitus, together with their clinicians, must make decisions concerning their plan of care and target glycaemic range. These patients require sufficient information to be capable of making informed decisions. It is imperative for clinicians and other health care professionals to have the skills to present patients with understandable and actionable information concerning individual treatments as well as levels and locations of care (U.S. Department of Veterans Affairs, 2017).
As a result, the recommendations in this guideline are designed to encourage shared decision-making and to be patient-centered. Clinicians and other health care professionals are encouraged to use the shared decision-making model to individualize treatment goals, objectives, and plans on the basis of patient capabilities, needs, goals, prior treatment experience, and preferences. Good communication between health care professionals and the patient is pivotal and should be supported by evidence-based information customized to the patient's needs. The use of an empathetic and non-judgmental approach facilitates discussions that are sensitive to gender, culture, and ethnic differences (Tschanz et al., 2018).
Information provided to patients regarding treatment and care should be culturally appropriate and accessible to individuals with limited literacy skills. It should also be readily available to persons with additional needs, such as physical, sensory, or learning disabilities. Health care professionals should consider involving the patient's family when necessary, particularly in the case of elderly patients. When the shared decision-making model is implemented properly, it may reduce patient anxiety, increase trust in clinicians, and enhance patient adherence to treatment. Enhanced communication between patient and clinician can also foster openness in discussing forthcoming concerns (U.S. Department of Veterans Affairs, 2017).
As part of the patient-centered care approach, it is imperative for health care professionals to assess the results of previous self-management efforts, past treatment experiences and outcomes, and any reasons for treatment dropout — together with the patient. They should also facilitate patient involvement in prioritizing problems to be addressed and assist patients in setting specific goals and objectives, regardless of the selected setting or level of care (U.S. Department of Veterans Affairs, 2017).
Research and References Supporting the Guideline
The healthcare system practice guideline incorporates an algorithm intended to facilitate comprehension of the clinical pathway and decision-making process used in the management of Diabetes Mellitus. The algorithm format was selected based on the understanding that this format can promote more effective diagnostic and therapeutic decision-making and has the potential to alter patterns of resource use. Acknowledging that a number of clinical care procedures are non-linear, the algorithm format allows the provider to follow a streamlined approach in examining the key information required at critical decision points in the clinical process. The algorithm comprises a well-arranged sequence of care steps, pertinent observations and examinations, decisions for consideration, and actions to be taken.
Conclusion
The discussed healthcare practice guideline outlines the significant decision points in the Management of Diabetes Mellitus and delivers properly outlined, wide-ranging, evidence-based recommendations integrating prevailing information and practices for practitioners throughout the Department of Defense (DoD) and Veterans Affairs (VA) Health Care Systems. These guidelines are centered on the best available information at the time of publication. They are intended to provide information and assist in decision-making, not to define a standard of care, and should not be interpreted as one. Based on the successive updates to the guideline, it can be concluded that professionals in the healthcare system follow these guidelines in their effort to provide patients with optimal care and to improve quality of life. The guidelines are informed by research comprising systematic reviews and meta-analyses of relevant RCTs, demonstrating that the level of evidence is Level I.
The healthcare practice guideline and its algorithms are intended to be adaptable to local needs and resources. The algorithm serves as a tool to prompt providers to consider key decision points throughout an episode of care. However, although this practice guideline represents state-of-the-art practice as of its publication date, medical practice continually evolves, and such evolution necessitates ongoing updating of clinical information. New technology and additional research will continue to enhance patient care in the future. The healthcare practice guideline can be beneficial in identifying priority areas for research and the optimal allocation of resources. Future research investigating the outcomes of guideline implementation may give rise to new evidence particularly relevant to clinical practice.
Overall, the expected outcome of this healthcare practice guideline on Diabetes Mellitus is to focus on shared decision-making between the healthcare professional and the patient to establish the patient's goals and objectives. There is also the expected outcome of assessing the patient's condition and determining — in collaboration with the patient — the most appropriate course of treatment to accomplish those goals. Finally, this system practice guideline is expected to contribute to a reduction in the risk of preventable health complications and to improve the quality of life for patients suffering from Diabetes Mellitus.
References
Burns, P. B., Rohrich, R. J., & Chung, K. C. (2011). The levels of evidence and their role in evidence-based medicine. Plastic and Reconstructive Surgery, 128(1), 305.
Tschanz, M. P., Colburn, M. J. A., Conlin, P. R., & Pogach, L. M. (2017). Overview and discussion of the 2017 VA/DoD clinical practice guideline for the management of Type 2 Diabetes Mellitus in primary care. Federal Practitioner.
U.S. Department of Veterans Affairs. (2017). Management of Diabetes Mellitus in Primary Care (2017). Retrieved from https://www.healthquality.va.gov/guidelines/CD/diabetes/
U.S. Department of Veterans Affairs. (2017). VA/DoD clinical practice guideline for the management of Type 2 Diabetes Mellitus in primary care. Retrieved from
Create your account
Always verify citation format against your institution’s current style guide requirements.